Virnich Daniel 4
4 · Oncology Institute, Inc. · Filed May 22, 2025
Insider Transaction Report
Form 4
Virnich Daniel
Chief Executive Officer
Transactions
- Disposition to Issuer
Common stock
2025-05-21$2.67/sh−20,388$54,538→ 1,787,309 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.